Mastitis Market Research Report - Global Forecast till 2023

Mastitis Market Research Report - Global Forecast till 2023

ID: MRFR/HC/3936-HCRR | | Region: Global | 95 pages | Half-Cooked Research Reports

Mastitis Market Research Report- Types (Contagious Mastitis, Environmental Mastitis) Diagnosis (Physical Examination, Others), Treatment (Antibiotics, Pain Relievers, Surgery), End User (Hospitals & Clinics, Research Centers) - Global Forecast till 2023  


Market Scenario


Mastitis is a breast infection, which results in breast pain, swelling, warmth, and redness. In most cases, lactation mastitis occurs within the first six to 12 weeks after giving birth (postpartum), but it can happen later during the breastfeeding. The major symptoms of mastitis include breast tenderness or warmth to the touch, malaise, breast swelling, pain or a burning sensation continuously or while breastfeeding, skin redness, often in a wedge-shaped pattern, high fever and others.


According to the WHO, breast cancer is the second most common type of cancer in women. Every year 200,000 new cases are diagnosed worldwide and the number is continuously increasing. Prevalence of breast cancer is more common in developed countries as compared to developing countries. The global breast cancer market is driven by increasing number of females having breast cancer. Adoption of an unhealthy lifestyle, exposure to harmful radiation, increasing female geriatric population, and increasing government initiatives also contributed to the growth of the market. Since no absolute treatment is available to completely cure the disease, there is a scope for developing effective treatments. On another hand, the high cost of the treatment, adverse effects associated with the therapy, and long approval time for the drugs may restrain the growth of the market. However, the high cost of the treatment is likely to affect the growth of the market, negatively.


The global mastitis market is expected to grow at a CAGR of ~7.6 % during the forecast period 2017-2023.


 Intended Audience



  • Pharmaceutical and Biotechnological Companies

  • Research and Development (R&D) Companies

  • Neurological Companies

  • Hospitals and Clinics

  • Academic Institutes and Universities


Figure 1: Global Mastitis Market Share, by Region, 2016 (%)

Mastitis Market


Sources: WHO, annual reports, press release, white paper, company presentation


Segmentations


The global mastitis market is segmented on the basis of types, diagnosis, treatment, and end users.


Based on the types, the market is segmented into contagious mastitis and environmental mastitis.


On the basis of the diagnosis, the market is segmented into the physical examination and others.


On the basis of the treatment, the market is segmented into antibiotics, pain relievers, surgery, and others. The pain relievers are further segmented into acetaminophen, ibuprofen, and others. Moreover, acetaminophen is segmented into Tylenol and others. Ibuprofen is further segmented into Advil, Motrin IB, and others.


On the basis of the end users, the market is segmented into hospital & clinics, research centers, and others.


Key Players


Some of the key the players in the market are Pfizer (U.S.), Novartis AG (Switzerland), Oncogenex (U.S.), Apthera Inc (U.K), BioNumerik Pharmaceuticals (U.S.), Oncothyreon Inc (U.S.), Astellas (Japan), Bipar Sciences (U.S.), Puma Biotechnology (U.S.), Sanofi S.A. (U.S.), Eli Lilly and Company (U.S.), AstraZeneca (U.K.), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline (U.K.), Genentech (U.S.), Teva Pharmaceutical Industries (Israel), Sun Pharmaceutical Industries Ltd (India), Accord Healthcare, Inc. (India), Gilead Sciences, Inc. (U.S.), and others.


Research Methodology

Mastitis Market 2018


Sources: WHO, annual reports, press release, white paper, and company presentation


Regional Analysis


The Americas dominate the global mastitis market owing to the increasing number of patients with various cancer such as mastitis, and rare diseases. Due to rapidly increasing patient population, governments have started supporting the manufacturers for the development of new and better drugs. Additionally, well-developed technology, high healthcare expenditure, and strong government support for research & development have fueled the growth of the market in this region.


Europe commands the second largest market for mastitis, which is followed by the Asia Pacific. Availability of funds, increasing need for better treatment options, and strong government support drive the growth of the market in Europe. Germany, France & the U.K are the major contributors to the European market growth.


The Asia Pacific is the fastest growing mastitis market owing to the increasing number of patients with cancers and the presence of a huge opportunity for the development of the market. Additionally, rapidly growing economies and increasing healthcare expenditure are likely to fuel the growth of the market over the assessment period.


On the other hand, the Middle East & Africa holds the least share of the market owing to less availability of funds, limited availability of medical facilities, and poor political conditions in Africa. The Middle East region holds the major share of the market owing to well-developed technology and high healthcare expenditure. On the other hand, African region shows the fastest growth due to the availability of opportunities for the market growth.

 Table of Content         

1.         Report Prologue          

2.         Market Introduction     

2.1        Definition         

2.2        Scope of the Study      

2.2.1     Research Objective      

2.2.2     Assumptions    

2.2.3     Limitations       

3.         Research Methodology

3.1        Introduction

3.2        Primary Research         

3.3        Secondary research      

3.4        Market Size Estimation

4.         Market Dynamics

4.1        Drivers 

4.2        Restrains

4.3        Opportunities   

4.4        Challenges

4.5        Macroeconomic Indicators

4.6        Technology Trends & Assessment                                

5.         Market Factor Analysis

5.1        Porters Five Forces Analysis

5.1.1     Bargaining Power of Suppliers  

5.1.2     Bargaining Power of Buyers

5.1.3     Threat of New Entrants 

5.1.4     Threat of Substitutes    

5.1.5     Intensity of Rivalry        

5.2        Value Chain Analysis

5.3        Investment Feasibility Analysis  

5.4        Pricing Analysis

6.         Global Mastitis Market, by Type

            6.1        Introduction

6.2        Contagious Mastitis

6.2.1     Market Estimates & Forecast, 2017-2023

6.3        Environmental Mastitis

6.3.1     Market Estimates & Forecast, 2017-2023

7.         Global Mastitis Market, by Diagnosis

            7.1        Introduction

7.2        Physical Examination

7.2.1     Market Estimates & Forecast, 2017-2023

7.3        Others

7.3.1     Market Estimates & Forecast, 2017-2023

8.         Global Mastitis Market, by Treatment

            8.1        Introduction

8.2        Antibiotics

8.2.1     Market Estimates & Forecast, 2017-2023

8.3        Pain Relievers

8.3.1     Market Estimates & Forecast, 2017-2023

8.4        Surgery

8.4.1     Market Estimates & Forecast, 2017-2023

9.         Global Mastitis Market, by End User

9.1        Introduction

9.2        Hospital & Clinics

9.2.1     Market Estimates & Forecast, 2017-2023

9.3        Research Centers

9.3.1     Market Estimates & Forecast, 2017-2023

9.3        Others

9.3.1     Market Estimates & Forecast, 2017-2023

10.        Global Mastitis Market, by Region

10.1      Introduction

10.2      Americas

10.2.1   North America

10.2.1.1 US

10.2.1.1 Canada

10.2.2   South America

10.3      Europe

10.3.1   Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 UK

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2   Eastern Europe

10.4      Asia Pacific

10.4.1   Japan

10.4.2   China

10.4.3   India

10.4.4   Australia

10.4.5   Republic of Korea

10.4.6   Rest of Asia Pacific

10.5      The Middle East & Africa

10.5.1   United Arab Emirates

10.5.2   Saudi Arabia

10.5.3   Oman

10.5.4   Kuwait

10.5.5   Qatar

10.5.6   Rest of the Middle East & Africa

11         Company Landscape   

11.1      Introduction      

11.2      Market Share Analysis  

11.3      Key Development & Strategies 

11.3.1   Key Developments       

12         Company Profiles       

12.1      Pfizer   

12.1.1   Company Overview      

12.1.2   Product Overview         

12.1.3   Financials        

12.1.4   SWOT Analysis

12.2      Novartis AG     

12.2.1   Company Overview      

12.2.2   Product Overview         

12.2.3   Financial Overview        

12.2.4   Key Developments       

12.2.5   SWOT Analysis

12.3      Oncogenex      

12.3.1   Company Overview      

12.3.2   Product Overview         

12.3.3   Financial Overview

12.3.4   Key Development         

12.3.5   SWOT Analysis

12.4      Apthera Inc

12.4.1   Company Overview      

12.4.2   Product/Business Segment Overview    

12.4.3   Financial Overview        

12.4.4   Key Development         

12.4.5   SWOT Analysis

12.5      BioNumerik Pharmaceuticals

12.5.1   Company Overview      

12.5.2   Product Overview         

12.5.3   Financial overview        

12.5.4   Key Developments       

12.6      Oncothyreon Inc

12.6.1   Company Overview      

12.6.2   Product Overview         

12.6.3   Financial Overview        

12.6.4   Key Developments       

12.7      Astellas

12.7.1   Overview          

12.7.2   Product Overview         

12.7.3   Financials        

12.7.4   Key Developments       

12.7.5   SWOT Analysis

            12.8      Others

13         MRFR Conclusion       

13.1      Key Findings    

13.1.1   From CEO’s View Point

13.1.2   Unmet Needs of the Market      

13.2      Key Companies to Watch         

13.3      Prediction of Pharmaceutical Industry

14         Appendix

 

LIST OF TABLES

Table 1             Mastitis Industry Synopsis, 2017-2023

Table 2             Global Mastitis Market Estimates and Forecast, 2017-2023, (USD Million)

Table 3             Global Mastitis Market by Region, 2017-2023, (USD Million)

Table 4             Global Mastitis Market by Types, 2017-2023, (USD Million)

Table 5             Global Mastitis Market by Diagnosis, 2017-2023, (USD Million)

Table 6             Global Mastitis Market by Treatment, 2017-2023, (USD Million)

Table 7             Global Mastitis Market by End Users, 2017-2023, (USD Million)

Table 8             North America Mastitis Market by Types, 2017-2023, (USD Million)

Table 9             North America Mastitis Market by Diagnosis, 2017-2023, (USD Million)

Table 10            North America Mastitis Market by Treatment, 2017-2023, (USD Million)

Table 11            North America Mastitis Market by End Users, 2017-2023, (USD Million)

Table 12            US Mastitis Market by Types, 2017-2023, (USD Million)

Table 13            US Mastitis Market by Diagnosis, 2017-2023, (USD Million)

Table 14            US Mastitis Market by Treatment, 2017-2023, (USD Million)

Table 15            US Mastitis Market by End Users, 2017-2023, (USD Million)

Table 16            Canada Mastitis Market by Types, 2017-2023, (USD Million)

Table 17            Canada Mastitis Market by Diagnosis, 2017-2023, (USD Million)

Table 18            Canada Mastitis Market by Treatment, 2017-2023, (USD Million)

Table 19            Canada Mastitis Market by End Users, 2017-2023, (USD Million)

Table 20            South America Mastitis Market by Types, 2017-2023, (USD Million)

Table 21            South America Mastitis Market by Diagnosis, 2017-2023, (USD Million)

Table 22            South America Mastitis Market by Treatment, 2017-2023, (USD Million)

Table 23            South America Mastitis Market by End Users, 2017-2023, (USD Million)

Table 24            Europe Mastitis Market by Types, 2017-2023, (USD Million)

Table 25            Europe Mastitis Market by Diagnosis, 2017-2023, (USD Million)

Table 26            Europe Mastitis Market by Treatment, 2017-2023, (USD Million)

Table 27            Europe Mastitis Market by End Users, 2017-2023, (USD Million)

Table 28            Western Europe Mastitis Market by Types, 2017-2023, (USD Million)

Table 29            Western Europe Mastitis Market by Diagnosis, 2017-2023, (USD Million)

Table 30            Western Europe Mastitis Market by Treatment, 2017-2023, (USD Million)

Table 31            Western Europe Mastitis Market by End Users, 2017-2023, (USD Million)

Table 32            Eastern Europe Mastitis Market by Types, 2017-2023, (USD Million)

Table 33            Eastern Europe Mastitis Market by Diagnosis, 2017-2023, (USD Million)

Table 34            Eastern Europe Mastitis Market by Treatment, 2017-2023, (USD Million)

Table 35            Eastern Europe Mastitis Market by End Users, 2017-2023, (USD Million)

Table 36            Asia Pacific Mastitis Market by Types, 2017-2023, (USD Million)

Table 37            Asia Pacific Mastitis Market by Diagnosis, 2017-2023, (USD Million)

Table 38            Asia Pacific Mastitis Market by Treatment, 2017-2023, (USD Million)

Table 39            Asia Pacific Mastitis Market by End Users, 2017-2023, (USD Million)

Table 40            Middle East & Africa Mastitis Market by Types, 2017-2023, (USD Million)

Table 41            Middle East & Africa Mastitis Market by Diagnosis, 2017-2023, (USD Million)

Table 42            Middle East & Africa Mastitis Market by Treatment, 2017-2023, (USD Million)

Table 43            Middle East & Africa Mastitis Market by End Users, 2017-2023, (USD Million)

LIST OF FIGURES

Figure 1            Research Process

Figure 2            Segmentation for Global Mastitis Market

Figure 3            Segmentation Market Dynamics for Mastitis Market

Figure 4            Global Mastitis Market Share, by Diagnosis 2016

Figure 5            Global Mastitis Market Share, by Treatment 2016

Figure 6            Global Mastitis Market Share, by End Users, 2016

Figure 7            Global Mastitis Market Share, by Region, 2016

Figure 8            North America Mastitis Market Share, by Country, 2016

Figure 9            Europe Mastitis Market Share, by Country, 2016

Figure 10          Asia Pacific Mastitis Market Share, by Country, 2016

Figure 11          Middle East & Africa Mastitis Market Share, by Country, 2016

Figure 12          Global Mastitis Market: Company Share Analysis, 2016 (%)

Figure 13          Pfizer: Key Financials

Figure 14          Pfizer: Segmental Revenue

Figure 16          Pfizer: Geographical Revenue

Figure 17          Novartis AG: Key Financials

Figure 18          Novartis AG: Segmental Revenue

Figure 19          Novartis AG: Geographical Revenue

Figure 20          Oncogenex: Key Financials

Figure 21          Oncogenex: Segmental Revenue

Figure 22          Oncogenex: Geographical Revenue

Figure 23          Apthera Inc: Key Financials

Figure 24          Apthera Inc: Segmental Revenue

Figure 25          Apthera Inc: Geographical Revenue

Figure 26          BioNumerik Pharmaceuticals: Key Financials

Figure 27          BioNumerik Pharmaceuticals: Segmental Revenue

Figure 28          BioNumerik Pharmaceuticals: Geographical Revenue

Figure 29          Oncothyreon Inc: Key Financials

Figure 30          Oncothyreon Inc: Segmental Revenue

Figure 31          Oncothyreon Inc: Geographical Revenue

Figure 32          Astellas: Key Financials

Figure 33          Astellas: Segmental Revenue

Figure 34          Astellas: Geographical Revenue